• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Hainan Poly Generic Gadoterate Meglumine Receives Approval in US

    17 Jun 2024 //

    FDA

    Fresenius Kabi Launches Gadoterate Meglumine Injection, USP

    04 Oct 2022 //

    BUSINESSWIRE

    Jiangsu Hengrui Medicine`s Generic Gadoterate Meglumine Receives Approval inU.S.

    15 Apr 2022 //

    FDA

    Jiangsu Hengrui`s Generic Gadoterate Meglumine Receives Approval in the U.S.

    11 Apr 2022 //

    FDA

    Health Canada Recalls Dotarem Injection

    22 Nov 2021 //

    HEALTH CANADA

    GE Healthcare`s Generic Gadoterate Meglumine Receives Approval in US

    06 Nov 2019 //

    FDA

    GE Healthcare Announces USFDA Approval Macrocyclic MRI Contrast Agent Clariscan

    04 Nov 2019 //

    BIOSPACE

    Gadolinium-based contrast agents: update from Guerbet LLC on U.S. FDA

    27 Dec 2017 //

    PR NEWSWIRE

    FDA Approves Guerbet`s Dotarem gadoterate meglumine Pediatric Patient Younger 2y

    05 Sep 2017 //

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.